MD, PhD. Professor, Department of Medicine, Universidade Federal de São Paulo (UNIFESP), São Paulo (SP), Brazil.
MD. Physician, Department of Electrophysiology, Hospital São Luiz and Hospital e Maternidade São Luiz, Unidade Itaim, São Paulo (SP), Brazil.
Sao Paulo Med J. 2022 Jan-Feb;140(1):71-80. doi: 10.1590/1516-3180.2021.0111.R1.18052021.
Although autonomic dysfunction has been shown to be associated with liver cirrhosis, the prevalence and prognostic implications are unclear. Abnormal heart rate variability (HRV), a measure of autonomic function, has not been well investigated in cirrhosis.
To evaluate the prevalence of high-risk HRV parameters in a cohort of cirrhotic patients and their association with cardiac dysfunction and mortality.
Prospective observational study conducted in the Federal University of São Paulo.
A cohort of 120 patients, comprising 17 healthy controls and 103 cirrhotic outpatients, was evaluated and followed for 10 months. HRV analysis was based on 24-hour Holter monitoring and defined using time-domain and frequency-domain parameters.
The HRV parameters were statistically lower in cirrhotic patients than in healthy subjects. High-risk HRV parameters were prevalent, such that 64% had at least one high-risk parameter. Time-domain parameters correlated with Child scores (P < 0.0001). In regression models, HRV parameters were independent predictors of diastolic dysfunction and mortality. During 10 months of follow-up, there were 11 deaths, all of patients with at least one high-risk HRV parameter. Kaplan-Meier analysis estimated low survival rates among patients with standard deviation of normal-to-normal RR intervals (SDNN) < 100.
Reduced HRV is prevalent in liver cirrhosis and is related to cardiac dysfunction, severity of liver disease and mortality. Abnormal high-risk HRV parameters are prevalent among cirrhotic patients and are also predictors of mortality. Our findings highlight the need for a more careful cardiac evaluation of cirrhotic patients.
尽管自主神经功能障碍与肝硬化有关,但目前尚不清楚其流行程度和预后意义。心率变异性(HRV)是自主功能的一种衡量标准,在肝硬化中尚未得到充分研究。
评估肝硬化患者队列中高危 HRV 参数的流行率及其与心脏功能障碍和死亡率的关系。
在圣保罗联邦大学进行的前瞻性观察性研究。
评估了 120 例患者(包括 17 名健康对照者和 103 名肝硬化门诊患者),并对其进行了 10 个月的随访。HRV 分析基于 24 小时动态心电图监测,并使用时域和频域参数进行定义。
与健康受试者相比,肝硬化患者的 HRV 参数明显降低。高危 HRV 参数很常见,有 64%的患者至少有一个高危参数。时域参数与 Child 评分相关(P<0.0001)。在回归模型中,HRV 参数是舒张功能障碍和死亡率的独立预测因子。在 10 个月的随访期间,有 11 例死亡,均为至少有一个高危 HRV 参数的患者。Kaplan-Meier 分析估计,正常到正常 RR 间隔标准差(SDNN)<100 的患者的生存率较低。
肝硬化患者的 HRV 降低较为普遍,与心脏功能障碍、肝病严重程度和死亡率有关。异常高危 HRV 参数在肝硬化患者中较为常见,也是死亡率的预测因子。我们的研究结果强调了对肝硬化患者进行更仔细的心脏评估的必要性。